SAN CARLOS, Calif. and HOPKINTON, Mass., Jan. 27, 2011 /PRNewswire/ -- NuGEN Technologies, Inc. and Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced a co-marketing agreement for the development of automated methods for next generation sequencing sample preparation on Caliper's Sciclone® NGS Workstation. The collaboration aims to enable researchers to leverage NuGEN's Ovation® and Encore™ reagent solutions on Caliper's liquid handling platforms to automate the processing of a wide range of sample types such as nucleic acids extracted from sorted cells, fine needle aspirates, formalin-fixed paraffin-embedded (FFPE) tissue, and other limited and compromised clinical samples.
Under this agreement, Caliper and NuGEN will first co-develop automation scripts for NuGEN's Ovation RNA-Seq System and Encore NGS Multiplex System I on Caliper's Sciclone NGS Workstation to provide end-to-end, high throughput library construction from as little as 500 pg of total RNA. The automation solution is scheduled to be available before the end of March 2011. The Sciclone NGS Workstation can be integrated with Caliper's LabChip® GX, which is an analytical QC platform, and the LabChip XT, a preparative nucleic acid fractionation platform, for extended hands-off automation. Additional applications will follow.
"NuGEN's Ovation RNA-Seq System is the first RNA-Seq preparation kit without any requirement for poly(A) selection or ribosomal RNA depletion," said Elizabeth Hutt, CEO of NuGEN Technologies. "Working from total RNA reduces the bias inherent in the selection steps, and results in a more complete data set and a more comprehensive understanding of the transcriptome including non-coding RNAs. Our sample preparation capabilities nicely complement Caliper's Sciclone NGS Workstation to provide our customers with a streamlined workflow and easy access to the most a
|SOURCE Caliper Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved